Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1α-mediated chemotaxis of human cord blood CD34+ progenitor cells

Journal of Immunology

Volumn 169, Issue 12, 2002, Pages 7000-7008

  Christopherson II, Kent W ^a   Hangoc, Giao ^a   Broxmeyer, Hal E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CHEMOKINE; DIPEPTIDYL PEPTIDASE IV; DIPROTIN A; PROLINE; STROMAL CELL DERIVED FACTOR 1ALPHA; ALPHA CHEMOKINE; OLIGOPEPTIDE; PROTEINASE INHIBITOR; STROMAL CELL DERIVED FACTOR 1;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL MIGRATION; CELL SURFACE; CHEMOTAXIS; ENZYME ACTIVITY; ENZYME INHIBITION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STEM CELL; UMBILICAL CORD BLOOD; AMINO ACID SEQUENCE; BIOSYNTHESIS; CELL MEMBRANE; CLONOGENIC ASSAY; CYTOLOGY; ENZYME ACTIVATION; ENZYMOLOGY; FETUS BLOOD; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; STROMA CELL;

AMINO ACID SEQUENCE; ANTIGENS, CD26; ANTIGENS, CD34; CELL MEMBRANE; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; COLONY-FORMING UNITS ASSAY; ENZYME ACTIVATION; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PROTEASE INHIBITORS; STROMAL CELLS;

EID: 0037114177     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.12.7000     Document Type: Article

References (41)

1. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature 392:565.
2. Pal, R., A. Garzino-Demo, P. D. Markham, J. Burns, M. Brown, R. C. Gallo, and A. L. DeVico. 1997. Inhibition of HIV-1 infection by the β-chemokine MDC. Science 278:695.
3. 2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor. J. Immunol. 161:2672.
4. Struyf, S., I. De Meester, S. Scharpe, J. P. Lenaerts, P. Menten, J. M. Wang, P. Proost, and J. Van Damme. 1998. Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor. Eur. J. Immunol. 28:1262.
5. 2-terminal heterogeneity. Functional comparison of different natural isoforms. Eur. J. Biochem. 260:421.
6. Tensen, C. P., J. Flier, E. M. Van Der Raaij-Helmer, S. Sampat-Sardjoepersad, R. C. Van Der Schors, R. Leurs, R. J. Scheper, D. M. Boorsma, and R. Willemze. 1999. Human IP-9: a keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). J. Invest. Dermatol. 112:716.
7. Noso, N., J. Bartels, A. I. Mallet, M. Mochizuki, E. Christophers, and J. M. Schroder. 1998. Delayed production of biologically active O-glycosylated forms of human eotaxin by tumor-necrosis-factor-α-stimulated dermal fibroblasts. Eur. J. Biochem. 253:114.
8. Vulcano, M., C. Albanesi, A. Stoppacciaro, R. Bagnati, G. D'Amico, S. Struyf, P. Transidico, R. Bonecchi, A. Del Prete, P. Allavena, et al. 2001. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur. J. Immunol. 31:812.
9. Bongers, J., T. Lambros, M. Ahmad, and E. P. Heimer. 1992. Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs. Biochim. Biophys. Acta 1122:147.
10. + T lymphocytes of HIV-infected subjects. J. Acquired Immune Defic. Syndr. 6:749.
11. Kahne, T., U. Lendeckel, S. Wrenger, K. Neubert, S. Ansorge, and D. Reinhold. 1999. Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth. Int. J. Mol. Med. 4:3.
12. Huhn, J., S. Ehrlich, B. Fleischer, and A. von Bonin. 2000. Molecular analysis of CD26-mediated signal transduction in T cells. Immunol. Lett. 72:127.
13. Durinx, C., A. M. Lambeir, E. Bosmans, J. B. Falmagne, R. Berghmans, A. Haemers, S. Scharpe, and I. De Meester. 2000. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. Eur. J. Biochem. 267:5608.
14. Mentlein, R. 1999. Dipeptidyl-peptidase IV (CD26): role in the inactivation of regulatory peptides. Regul. Pept. 85:9.
15. Oravecz, T., M. Pall, G. Roderiquez, M. D. Gorrell, M. Ditto, N. Y. Nguyen, R. Boykins, E. Unsworth, and M. A. Norcross. 1997. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J. Exp. Med. 186:1865.
16. Schols, D., P. Proost, S. Struyf, A. Wuyts, I. De Meester, S. Scharpe, J. Van Damme, and E. De Clercq. 1998. CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity. Antiviral Res. 39:175.
17. Proost, P., I. De Meester, D. Schols, S. Struyf, A. M. Lambeir, A. Wuyts, G. Opdenakker, E. De Clercq, S. Scharpe, and J. Van Damme. 1998. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV: conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J. Biol. Chem. 273:7222.
18. Proost, P., S. Struyf, D. Schols, C. Durinx, A. Wuyts, J. P. Lenaerts, E. De Clercq, I. De Meester, and J. Van Damme. 1998. Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1α. FEBS Lett. 432:73.
19. Shioda, T., H. Kato, Y. Ohnishi, K. Tashiro, M. Ikegawa, E. E. Nakayama, H. Hu, A. Kato, Y. Sakai, H. Liu, et al. 1998. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proc. Natl. Acad. Sci. USA 95:6331.
20. Van Coillie, E., P. Proost, I. Van Aelst, S. Struyf, M. Polfliet, I. De Meester, D. J. Harvey, J. Van Damme, and G. Opdenakker. 1998. Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV. Biochemistry 37:12672.
21. Struyf, S., P. Proost, D. Schols, E. De Clercq, G. Opdenakker, J. P. Lenaerts, M. Detheux, M. Parmentier, I. De Meester, S. Scharpe, et al. 1999. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. J. Immunol. 162:4903.
22. Proost, P., S. Struyf, D. Schols, G. Opdenakker, S. Sozzani, P. Allavena, A. Mantovani, K. Augustyns, G. Bal, A. Haemers, et al. 1999. Truncation of macrophage-derived chemokine by CD26/dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction. J. Biol. Chem. 274:3988.
23. Iwata, S., N. Yamaguchi, Y. Munakata, H. Ikushima, J. F. Lee, O. Hosono, S. F. Schlossman, and C. Morimoto. 1999. CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response. Int. Immunol. 11:417.
24. Proost, P., P. Menten, S. Struyf, E. Schutyser, I. De Meester, and J. Van Damme. 2000. Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist. Blood 96:1674.
25. Lambeir, A. M., P. Proost, C. Durinx, G. Bal, K. Senten, K. Augustyns, S. Scharpe, J. Van Damme, and I. De Meester. 2001. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J. Biol. Chem. 276:29839.
26. + progenitors to peripheral blood. J. Exp. Med. 185:111.
27. Kim, C. H., and H. E. Broxmeyer. 1998. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood 91:100.
28. Broxmeyer, H. E. 2001. Regulation of hematopoiesis by chemokine family members. Int. J. Hematol. 74:9.
29. + progenitor cells express CD26 and contain increased dipeptidyl peptidase IV activity. Acta Haematol. 100:110.
30. Broxmeyer, H. E., G. W. Douglas, G. Hangoc, S. Cooper, J. Bard, D. English, M. Arny, L. Thomas, and E. A. Boyse. 1989. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc. Natl. Acad. Sci. USA 86:3828.
31. Gluckman, E., H. A. Broxmeyer, A. D. Auerbach, H. S. Friedman, G. W. Douglas, A. Devergie, H. Esperou, D. Thierry, G. Socie, P. Lehn, et al. 1989. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321: 1174.
32. Broxmeyer, H., and F. Smith. 1999. Cord blood stem cell transplantation. In Hematopoietic Cell Transplantation. S. J. Forman, K. G. Blume, and E. D. Thomas, eds. Blackwell Science, Oxford, U.K., and Malden, MA, p. 431.
33. Kojima, K., T. Hama, T. Kato, and T. Nagatsu. 1980. Rapid chromatographic purification of dipeptidyl peptidase IV in human submaxillary gland. J. Chromatogr. 189:233.
34. Nagatsu, T., M. Hino, H. Fuyamada, T. Hayakawa, and S. Sakakibara. 1976. New chromogenic substrates for X-prolyl dipeptidyl-aminopeptidase. Anal. Biochem. 74:466.
35. Christopherson, K. W., Jr., J. J. Campbell, and R. A. Hromas. 2001. Transgenic overexpression of the CC chemokine CCL21 disrupts T-cell migration. Blood 98:3562.
36. Christopherson, K., Jr., Z. Brahmi, and R. Hromas. 1999. Regulation of naive fetal T-cell migration by the chemokines Exodus-2 and Exodus-3. Immunol. Lett. 69:269.
37. Cooper, S., and H. E. Broxmeyer. 1996. Measurement of interleukin-3 and other hematopoietic growth factors, such as GM-CSF, G-CSF, M-CSF, erkythropoietin and the potent co-stimulating cyktokines steel factor and FLt-3 ligand. In Current Protocols in Immunology. K. A. Coligan, D. H. Margulies, E. M. Shevach, E. Strober, and R. Coico, eds. John Wiley & Sons. New York, p. 6.4.1.
38. Broxmeyer, H. E., G. Hangoc, S. Cooper, R. C. Ribeiro, V. Graves, M. Yoder, J. Wagner, S. Vadhan-Raj, L. Benninger, P. Rubinstein, et al. 1992. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc. Natl. Acad. Sci. USA 89:4109.
39. Schon, E., H. U. Demuth, A. Barth, and S. Ansorge. 1984. Dipeptidyl peptidase IV of human lymphocytes: evidence for specific hydrolysis of glycylproline pnitroanilide in T-lymphocytes. Biochem. J. 223:255.
40. Petit, I., M. Szyper-Kravitz, A. Nagler, M. Lahav, A. Peled, L. Habler, T. Ponomaryov, R. S. Taichman, F. Arenzana-Seisdedos, N. Fujii, et al. 2002. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3:687.
41. Peled, A., I. Petit, O. Kollet, M. Magid, T. Ponomaryov, T. Byk, A. Nagler, H. Ben-Hur, A. Many, L. Shultz, et al. 1999. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283:845.